Provided by Tiger Trade Technology Pte. Ltd.

Illumina

116.38
-2.9400-2.46%
Post-market: 116.27-0.1100-0.09%19:09 EST
Volume:2.03M
Turnover:238.33M
Market Cap:17.78B
PE:21.35
High:119.17
Open:118.29
Low:116.20
Close:119.32
52wk High:155.53
52wk Low:68.70
Shares:152.80M
Float Shares:149.35M
Volume Ratio:0.66
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.45
EPS(LYR):5.45
ROE:33.36%
ROA:8.48%
PB:6.53
PE(LYR):21.35

Loading ...

Illumina Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 10

Illumina Earnings Call Highlights Clinical Growth Momentum

TIPRANKS
·
Feb 07

Illumina Is Maintained at Neutral by JP Morgan

Dow Jones
·
Feb 07

Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Ocular Therapeutix (OCUL)

TIPRANKS
·
Feb 07

Illumina Down Over 9%, on Pace for Largest percent Decrease Since May 2022 -- Data Talk

Dow Jones
·
Feb 07

UBS Adjusts Illumina Price Target to $135 From $120, Maintains Neutral Rating

MT Newswires Live
·
Feb 06

Stock Track | Illumina Plummets 9.09% Intraday on Mixed 2026 Guidance and JP Morgan Price Target Cut

Stock Track
·
Feb 06

Shares of Illumina Down 6.8% After Q4 Results

THOMSON REUTERS
·
Feb 06

Illumina price target raised to $135 from $120 at UBS

TIPRANKS
·
Feb 06

Guggenheim Reaffirms Their Buy Rating on Illumina (ILMN)

TIPRANKS
·
Feb 06

Illumina (ILMN) Receives a Hold from Canaccord Genuity

TIPRANKS
·
Feb 06

Shares of Illumina Down 5.9% Premarket After Q4 Results

THOMSON REUTERS
·
Feb 06

Illumina (ILMN) Gets a Sell from Barclays

TIPRANKS
·
Feb 06

Stock Track | Illumina Plunges 8.47% in Pre-Market on Mixed Earnings Outlook and JP Morgan Target Price Cut

Stock Track
·
Feb 06

Stock Track | Illumina Plunges 8.13% in Post-Market on Mixed Earnings Outlook

Stock Track
·
Feb 06

Illumina Posts Higher 4Q Profit, Revenue

Dow Jones
·
Feb 06

Standard BioTools Amends Financials After SomaLogic Sale to Illumina

Reuters
·
Feb 06

Stock Track | Illumina Plunges 5.7% After-Hours on Mixed Earnings Outlook

Stock Track
·
Feb 06

Illumina reports Q4 adjusted EPS $1.35, consensus $1.23

TIPRANKS
·
Feb 06

Illumina sees FY26 adjusted EPS $5.05-$5.20, consensus $5.07

TIPRANKS
·
Feb 06